211 related articles for article (PubMed ID: 10588466)
1. Antithrombotic activities of green tea catechins and (-)-epigallocatechin gallate.
Kang WS; Lim IH; Yuk DY; Chung KH; Park JB; Yoo HS; Yun YP
Thromb Res; 1999 Nov; 96(3):229-37. PubMed ID: 10588466
[TBL] [Abstract][Full Text] [Related]
2. Antiplatelet and antithrombotic activities of NQ301, 2-chloro-3-(4-acetophenyl)-amino-1,4-naphthoquinone.
Kang WS; Ryu CK; Chung KH; Ko MW; Joo JC; Yuk DY; Yoo HS; Yun YP
Biol Pharm Bull; 1999 Dec; 22(12):1284-7. PubMed ID: 10746156
[TBL] [Abstract][Full Text] [Related]
3. Antiplatelet activity of epigallocatechin gallate is mediated by the inhibition of PLCgamma2 phosphorylation, elevation of PGD2 production, and maintaining calcium-ATPase activity.
Jin YR; Im JH; Park ES; Cho MR; Han XH; Lee JJ; Lim Y; Kim TJ; Yun YP
J Cardiovasc Pharmacol; 2008 Jan; 51(1):45-54. PubMed ID: 18209568
[TBL] [Abstract][Full Text] [Related]
4. Studies on the antithrombotic and antiplatelet activities of NQ304, a newly synthesized naphthoquinone derivative.
Yuk DY; Lee HY; Ryu CK; Hong JT; Kang WS; Yoo HS; Yun YP
Arzneimittelforschung; 2000 Mar; 50(3):254-9. PubMed ID: 10758777
[TBL] [Abstract][Full Text] [Related]
5. Antithrombotic and antiplatelet activities of 2-chloro-3-[4-(ethylcarboxy)-phenyl]-amino-1,4-naphthoquinone (NQ12), a newly synthesized 1,4-naphthoquinone derivative.
Yuk DY; Ryu CK; Hong JT; Chung KH; Kang WS; Kim Y; Yoo HS; Lee MK; Lee CK; Yun YP
Biochem Pharmacol; 2000 Oct; 60(7):1001-8. PubMed ID: 10974210
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of J78, a newly synthesized 1,4-naphthoquinone derivative, on experimental thrombosis and platelet aggregation.
Jin YR; Ryu CK; Moon CK; Cho MR; Yun YP
Pharmacology; 2004 Apr; 70(4):195-200. PubMed ID: 15001820
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antiplatelet effects of the new antithrombotic agent aspalatone with low ulcerogenicity.
Han BH; Suh DY; Yang HO; Park YH; Kang YH; Kim YC
Arzneimittelforschung; 1994 Oct; 44(10):1122-6. PubMed ID: 7818584
[TBL] [Abstract][Full Text] [Related]
8. Antiplatelet activity of green tea catechins is mediated by inhibition of cytoplasmic calcium increase.
Kang WS; Chung KH; Chung JH; Lee JY; Park JB; Zhang YH; Yoo HS; Yun YP
J Cardiovasc Pharmacol; 2001 Dec; 38(6):875-84. PubMed ID: 11707691
[TBL] [Abstract][Full Text] [Related]
9. Antiplatelet and antithrombotic activities of Korean Red Ginseng.
Yu JY; Jin YR; Lee JJ; Chung JH; Noh JY; You SH; Kim KN; Im JH; Lee JH; Seo JM; Han HJ; Lim Y; Park ES; Kim TJ; Shin KS; Wee JJ; Park JD; Yun YP
Arch Pharm Res; 2006 Oct; 29(10):898-903. PubMed ID: 17121186
[TBL] [Abstract][Full Text] [Related]
10. Antiplatelet and antithrombotic activities of CP201, a newly synthesized 1,4-naphthoquinone derivative.
Jin YR; Hwang KA; Cho MR; Kim SY; Kim JH; Ryu CK; Son DJ; Park YH; Yun YP
Vascul Pharmacol; 2004 Feb; 41(1):35-41. PubMed ID: 15135330
[TBL] [Abstract][Full Text] [Related]
11. Antithrombotic activity of methanolic extract of Umbilicaria esculenta.
Kim MS; Lee KA
J Ethnopharmacol; 2006 May; 105(3):342-5. PubMed ID: 16384677
[TBL] [Abstract][Full Text] [Related]
12. An ethanol extract of Ramulus mori improves blood circulation by inhibiting platelet aggregation.
Lee J; Kwon G; Park J; Kim JK; Choe SY; Seo Y; Lim YH
Biosci Biotechnol Biochem; 2016 Jul; 80(7):1410-5. PubMed ID: 26967156
[TBL] [Abstract][Full Text] [Related]
13. Complex effects of different green tea catechins on human platelets.
Lill G; Voit S; Schrör K; Weber AA
FEBS Lett; 2003 Jul; 546(2-3):265-70. PubMed ID: 12832052
[TBL] [Abstract][Full Text] [Related]
14. Antithrombotic and antiplatelet activities of Korean red ginseng extract.
Jin YR; Yu JY; Lee JJ; You SH; Chung JH; Noh JY; Im JH; Han XH; Kim TJ; Shin KS; Wee JJ; Yun YP
Basic Clin Pharmacol Toxicol; 2007 Mar; 100(3):170-5. PubMed ID: 17309520
[TBL] [Abstract][Full Text] [Related]
15. Local delivery of green tea catechins inhibits neointimal formation in the rat carotid artery injury model.
Kim DW; Park YS; Kim YG; Piao H; Kwon JS; Hwang KK; Youn TJ; Park JB; Yun YP; Sachinidis A; Kim CH; Cho MC; Ahn HY
Heart Vessels; 2004 Sep; 19(5):242-7. PubMed ID: 15372300
[TBL] [Abstract][Full Text] [Related]
16. Effect of vintoperol on platelet aggregation and experimental thrombosis.
Csomor K; Kárpáti E
Arzneimittelforschung; 1994 Jan; 44(1):36-40. PubMed ID: 8135876
[TBL] [Abstract][Full Text] [Related]
17. YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits platelet-rich thrombosis in mice.
Teng CM; Wu CC; Ko FN; Lee FY; Kuo SC
Eur J Pharmacol; 1997 Feb; 320(2-3):161-6. PubMed ID: 9059849
[TBL] [Abstract][Full Text] [Related]
18. Antithrombotic and fibrinolytic activities of methanolic extract of aged sorghum vinegar.
Fan J; Zhang Y; Chang X; Zhang B; Jiang D; Saito M; Li Z
J Agric Food Chem; 2009 Sep; 57(18):8683-7. PubMed ID: 19754177
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelet and antithrombotic effects of cordycepin-enriched WIB-801CE from Cordyceps militaris ex vivo, in vivo, and in vitro.
Kwon HW; Shin JH; Lim DH; Ok WJ; Nam GS; Kim MJ; Kwon HK; Noh JH; Lee JY; Kim HH; Kim JL; Park HJ
BMC Complement Altern Med; 2016 Dec; 16(1):508. PubMed ID: 27927214
[TBL] [Abstract][Full Text] [Related]
20. (-)-Epigallocatechin gallate selectively inhibits adenosine diphosphate‑stimulated human platelet activation: suppression of heat shock protein 27 phosphorylation via p38 mitogen‑activated protein kinase.
Iida Y; Doi T; Matsushima-Nishiwaki R; Tokuda H; Ogura S; Kozawa O; Iida H
Mol Med Rep; 2014 Sep; 10(3):1383-8. PubMed ID: 25059833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
